- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 0.48 | -14.72 | 42.34 | 3.98 | 8.17 | 1.45 | N/A | - | ||
2024/10 | 0.56 | 35.0 | 91.01 | 3.5 | 4.73 | 1.39 | N/A | 因應產業趨勢調整客戶結構 | ||
2024/9 | 0.42 | 0.25 | 19.14 | 2.94 | -3.57 | 1.18 | 1.06 | - | ||
2024/8 | 0.41 | 19.33 | 7.53 | 2.52 | -6.5 | 1.05 | 1.19 | - | ||
2024/7 | 0.35 | 19.82 | 6.9 | 2.11 | -8.84 | 0.96 | 1.3 | - | ||
2024/6 | 0.29 | -10.36 | -21.13 | 1.76 | -11.41 | 0.9 | 1.45 | - | ||
2024/5 | 0.32 | 13.26 | 32.72 | 1.47 | -9.21 | 0.89 | 1.46 | - | ||
2024/4 | 0.29 | 1.04 | -2.08 | 1.15 | -16.61 | 0.8 | 1.63 | - | ||
2024/3 | 0.28 | 23.54 | -42.52 | 0.86 | -20.51 | 0.86 | 1.54 | - | ||
2024/2 | 0.23 | -35.26 | -40.72 | 0.58 | -2.36 | 1.0 | 1.33 | - | ||
2024/1 | 0.35 | -16.06 | 68.03 | 0.35 | 68.03 | 1.11 | 1.2 | 去年因景氣低迷影響營收甚鉅,今年營收情形與前年類似並無特殊異常 | ||
2023/12 | 0.42 | 25.23 | 2.13 | 4.1 | -28.16 | 1.05 | 1.23 | - | ||
2023/11 | 0.34 | 14.43 | -14.43 | 3.67 | -30.51 | 0.98 | 1.32 | - | ||
2023/10 | 0.29 | -15.79 | -44.08 | 3.34 | -31.8 | 1.03 | 1.26 | - | ||
2023/9 | 0.35 | -9.51 | -39.84 | 3.05 | -30.33 | 1.06 | 1.26 | - | ||
2023/8 | 0.39 | 18.63 | -20.44 | 2.7 | -28.88 | 1.08 | 1.24 | - | ||
2023/7 | 0.32 | -11.59 | -35.85 | 2.31 | -30.11 | 0.93 | 1.42 | - | ||
2023/6 | 0.37 | 50.84 | -28.39 | 1.99 | -29.07 | 0.9 | 1.51 | - | ||
2023/5 | 0.24 | -16.43 | -47.62 | 1.62 | -29.23 | 1.03 | 1.33 | - | ||
2023/4 | 0.29 | -40.68 | -44.44 | 1.38 | -24.55 | 1.17 | 1.16 | - | ||
2023/3 | 0.49 | 27.41 | -5.62 | 1.09 | -16.54 | 1.09 | 1.28 | - | ||
2023/2 | 0.39 | 83.5 | 0.56 | 0.6 | -23.81 | 1.01 | 1.38 | - | ||
2023/1 | 0.21 | -48.98 | -47.26 | 0.21 | -47.26 | 1.01 | 1.37 | - | ||
2022/12 | 0.41 | 4.9 | -7.03 | 5.7 | 15.61 | 1.33 | 1.03 | - | ||
2022/11 | 0.39 | -25.21 | -2.46 | 5.29 | 17.85 | 1.5 | 0.92 | - | ||
2022/10 | 0.52 | -9.41 | 8.75 | 4.9 | 19.85 | 1.59 | 0.86 | - | ||
2022/9 | 0.58 | 19.67 | 18.55 | 4.37 | 21.33 | 1.57 | 0.91 | 受新冠肺炎影響所致 | ||
2022/8 | 0.48 | -4.35 | 6.17 | 3.79 | 21.77 | 1.5 | 0.95 | - | ||
2022/7 | 0.51 | -1.31 | 24.21 | 3.31 | 24.44 | 1.48 | 0.96 | - | ||
2022/6 | 0.51 | 10.33 | 30.94 | 2.8 | 24.48 | 1.5 | 0.99 | - | ||
2022/5 | 0.46 | -11.36 | 9.76 | 2.29 | 23.12 | 1.51 | 0.98 | - | ||
2022/4 | 0.52 | 0.75 | 41.72 | 1.83 | 27.06 | 1.43 | 1.04 | - | ||
2022/3 | 0.52 | 35.78 | 20.77 | 1.3 | 21.98 | 1.3 | 1.12 | - | ||
2022/2 | 0.38 | -3.78 | 42.51 | 0.78 | 22.79 | 1.22 | 1.19 | - | ||
2022/1 | 0.4 | -10.05 | 8.37 | 0.4 | 8.37 | 1.24 | 1.17 | - | ||
2021/12 | 0.44 | 10.06 | 5.79 | 4.93 | 33.55 | 1.33 | 1.14 | 受新冠肺炎疫情影響 | ||
2021/11 | 0.4 | -16.61 | 49.0 | 4.49 | 37.1 | 1.37 | 1.1 | 受疫情影響 | ||
2021/10 | 0.48 | -1.25 | 72.17 | 4.09 | 36.03 | 1.43 | 1.06 | 受新冠肺炎影響所致 | ||
2021/9 | 0.49 | 7.17 | 41.44 | 3.6 | 32.32 | 1.35 | 1.09 | - | ||
2021/8 | 0.46 | 11.89 | 77.52 | 3.11 | 30.99 | 1.25 | 1.17 | 受新冠肺炎影響 | ||
2021/7 | 0.41 | 4.03 | 18.12 | 2.66 | 25.34 | 1.22 | 1.2 | - | ||
2021/6 | 0.39 | -7.51 | 66.64 | 2.25 | 26.74 | 1.18 | 1.16 | 受疫情影響 | ||
2021/5 | 0.42 | 14.44 | 164.77 | 1.86 | 20.65 | 1.22 | 1.13 | 受疫情影響所致 | ||
2021/4 | 0.37 | -14.13 | 146.41 | 1.44 | 3.98 | 1.07 | 1.29 | 去年受疫情影響,今年回升 | ||
2021/3 | 0.43 | 60.21 | 1.65 | 1.07 | -13.36 | 1.07 | 1.27 | - | ||
2021/2 | 0.27 | -26.83 | -41.72 | 0.64 | -21.24 | 1.05 | 1.28 | - | ||
2021/1 | 0.37 | -12.18 | 6.0 | 0.37 | 6.0 | 1.06 | 1.28 | - | ||
2020/12 | 0.42 | 55.0 | -10.33 | 3.69 | -40.93 | 0.97 | 1.25 | - | ||
2020/11 | 0.27 | -3.64 | -50.53 | 3.27 | -43.4 | 0.9 | 1.35 | 受新冠肺炎影響所致 | ||
2020/10 | 0.28 | -18.87 | -49.22 | 3.0 | -42.65 | 0.88 | 1.37 | - | ||
2020/9 | 0.35 | 34.51 | -23.92 | 2.72 | -41.88 | 0.95 | 1.17 | - | ||
2020/8 | 0.26 | -25.53 | -59.82 | 2.38 | -43.8 | 0.84 | 1.33 | 受新冠肺炎疫情影響 | ||
2020/7 | 0.34 | 46.77 | -37.85 | 2.12 | -40.94 | 0.74 | 1.5 | - | ||
2020/6 | 0.23 | 46.95 | -44.25 | 1.78 | -41.51 | 0.54 | 2.35 | - | ||
2020/5 | 0.16 | 6.5 | -72.88 | 1.54 | -41.07 | 0.73 | 1.74 | 因新冠肺炎疫情影響 | ||
2020/4 | 0.15 | -64.57 | -76.22 | 1.38 | -31.81 | 1.04 | 1.24 | 受新冠肺炎疫情影響所致 | ||
2020/3 | 0.42 | -8.15 | -13.51 | 1.23 | -11.72 | 1.23 | 1.1 | - | ||
2020/2 | 0.46 | 33.1 | 37.72 | 0.81 | -10.76 | 1.27 | 1.06 | - | ||
2020/1 | 0.35 | -25.72 | -39.23 | 0.35 | -39.23 | 0.0 | N/A | - | ||
2019/12 | 0.47 | -14.48 | -40.72 | 6.25 | -20.55 | 0.0 | N/A | - |
年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
---|---|---|---|---|---|---|---|---|---|
2024/1 | 0.35 | 2023/1 | 0.21 | 2022/1 | 0.4 | 2021/1 | 0.37 | 2020/1 | 0.35 |
2024/2 | 0.23 | 2023/2 | 0.39 | 2022/2 | 0.38 | 2021/2 | 0.27 | 2020/2 | 0.46 |
2024/3 | 0.28 | 2023/3 | 0.49 | 2022/3 | 0.52 | 2021/3 | 0.43 | 2020/3 | 0.42 |
2024/4 | 0.29 | 2023/4 | 0.29 | 2022/4 | 0.52 | 2021/4 | 0.37 | 2020/4 | 0.15 |
2024/5 | 0.32 | 2023/5 | 0.24 | 2022/5 | 0.46 | 2021/5 | 0.42 | 2020/5 | 0.16 |
2024/6 | 0.29 | 2023/6 | 0.37 | 2022/6 | 0.51 | 2021/6 | 0.39 | 2020/6 | 0.23 |
2024/7 | 0.35 | 2023/7 | 0.32 | 2022/7 | 0.51 | 2021/7 | 0.41 | 2020/7 | 0.34 |
2024/8 | 0.41 | 2023/8 | 0.39 | 2022/8 | 0.48 | 2021/8 | 0.46 | 2020/8 | 0.26 |
2024/9 | 0.42 | 2023/9 | 0.35 | 2022/9 | 0.58 | 2021/9 | 0.49 | 2020/9 | 0.35 |
2024/10 | 0.56 | 2023/10 | 0.29 | 2022/10 | 0.52 | 2021/10 | 0.48 | 2020/10 | 0.28 |
2024/11 | 0.48 | 2023/11 | 0.34 | 2022/11 | 0.39 | 2021/11 | 0.4 | 2020/11 | 0.27 |
N/A | N/A | 2023/12 | 0.42 | 2022/12 | 0.41 | 2021/12 | 0.44 | 2020/12 | 0.42 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債 QoQ YoY | |||
---|---|---|---|
24Q3 (20) | 0.01 | 0 | 0 |